O
Oragenics D
D
OGEN
0.37000
USD
0.01
(2.78%)
مغلق
حجم التداول
0
الربح لكل سهم
-11
العائد الربحي
-
P/E
-0
حجم السوق
4,526,832
الأخبار
المقالات
العنوان: Oragenics
القطاع: Healthcare
الصناعة: Biotechnology
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.